"10.1371_journal.pone.0061514","plos one","2013-04-18T00:00:00Z","Adams Amantana; Yali Chen; Shanthakumar R Tyavanagimatt; Kevin F Jones; Robert Jordan; Jarasvech Chinsangaram; Tove′ C Bolken; Janet M Leeds; Dennis E Hruby","SIGA Technologies Inc., Corvallis, Oregon, United States of America; Gilead Sciences Inc., Foster City, California, United States of America","Conceived and designed the experiments: AA YC SRT KFJ RJ JC TCB JML DEH. Analyzed the data: AA YC SRT JML. Wrote the paper: AA YC SRT KFJ RJ JC TCB JML DEH.","The authors have the following interests. Adams Amantana, Yali Chen, Shanthakumar R. Tyavanagimatt, Kevin F. Jones, Jarasvech Chinsangaram, Tove′ C. Bolken, Janet M. Leeds and Dennis E. Hruby are employed by SIGA Technologies, Inc. Robert Jordan was an employee of SIGA Technologies Inc., at the time of generating the data and drafting the initial version of this manuscript but has since joined Gilead Sciences, Foster City, CA. SIGA Technologies holds the patent on the drug being investigated in this study (ST-246). There are no further patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2013","04","Adams Amantana","AA",9,TRUE,9,NA,4,9,TRUE,TRUE,FALSE,0,NA,FALSE
